People v. Cancer

People v. Cancer

Join us for People v. Cancer 2023.



In the 2021 People v. Cancer summit, The Atlantic explored the latest science and the important ways in which prevention, diagnosis, treatment, and well-being are interrelated. Even in the midst of a global pandemic, progress continues to be made toward not only treating cancer and extending lives, but creating a more robust, holistic ecosystem of care.

We brought together medical providers, scientists, survivors, and patients for in-depth conversations about a disease that remains one of the world’s most complex, and most lethal. At People v. Cancer, The Atlantic explored the most crucial questions of the day: What is the future of cancer care? What can be done to improve lives for all—along the entire spectrum of care?

#PeopleVCancerWatch Now

Atlantic subscribers enjoy access to exclusive sessions and experiences.

Sign in or Subscribe
See All Speakers
  • Martin Edelman

    Chair, Lung Cancer Foundation of America’s Scientific Advisory Board

  • Amanda R. Ferrero

    Survivor and Patient Advocate

  • Andrea Ferris

    President and CEO, LUNGevity Foundation

    Underwriter Session

  • Elizabeth Fox

    Senior Vice President, Clinical Trials Research, St. Jude Children’s Research Hospital

    Twitter
  • Ginger Gardner

    Vice Chair, Hospital Operations, Department of Surgery at Memorial Sloan Kettering Cancer Center and Chair, Foundation for Women’s Cancer

  • Patricia J. Goldsmith

    CEO, CancerCare

    Underwriter Session

  • James Hamblin

    Contributor, The Atlantic

    Twitter
  • Garret Hampton

    President, Clinical Next Generation Sequencing Division, Thermo Fisher Scientific

    Underwriter Session

  • Karen Knudsen

    President and CEO, The American Cancer Society (ACS) and The American Cancer Society Action Network (ACS CAN)

    Twitter
  • Christopher S. Lathan

    Chief Clinical Access and Equity Officer, Associate Medical Director, Dana-Farber Cancer Institute Network

    Twitter
  • Vincent Laudone

    Chief of Surgery, Josie Robertson Surgery Center, Memorial Sloan Kettering Cancer Center

  • Jeanne Meserve

    Contributor, AtlanticLIVE

    Twitter
  • Marleen Meyers

    Director of Cancer Survivorship, Perlmutter Cancer Center, NYU Langone

    Twitter
  • Candace Montgomery

    Senior Vice President and General Manager, AtlanticLIVE

  • Amanda Mull

    Staff Writer, The Atlantic

  • Jill O’Donnell-Tormey

    CEO and Director of Scientific Affairs, Cancer Research Institute

    Twitter
  • Solange Peters

    Centre Hospitalier Universitaire Vaudois (CHUV) Oncology Department, Lausanne, President of the European Society of Medical Oncology

    Underwriter Session

  • Alyx Porter

    Neurologist, Mayo Clinic and Author, Navigating Life with a Brain Tumor

    Twitter
  • Al Roker

    Weather and Feature Anchor, Today, and Co-host, Third Hour of Today

    Twitter
  • Nina Shah

    Professor of Clinical Medicine, Division of Hematology-Oncology, University of California San Francisco

    Underwriter Session

  • Padmanee Sharma

    Professor, Genitourinary Medical Oncology and Immunology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center

    Underwriter Session

  • Ned Sharpless

    Director, National Cancer Institute

    Twitter
  • Jonathan W. Simons

    Prostate Cancer Foundation Board of Directors, Medical Director and Chief Science Officer, Marcus Foundation

  • Luke Timmerman

    Founder and Editor, Timmerman Report

    Underwriter Session

  • Hayley Romer

    Publisher and Chief Revenue Officer, The Atlantic

    Underwriter Session

  • Andy Schmeltz

    Global President and General Manager, Pfizer Oncology

    Underwriter Session

  • Fyodor Urnov

    Professor, Molecular and Cell Biology Department, UC Berkeley and Scientific Director, Technology and Translation, Innovative Genomics Institute

    Underwriter Session

  • Christine Ward

    Vice President, Precision and Translational Medicine, Oncology Cell Therapy Therapeutic Area Unit, Takeda Oncology

    Underwriter Session

  • Tony Wood

    SVP Medicinal Science and Technology, GSK

    Underwriter Session

  • Sarah Zhang

    Staff Writer, The Atlantic

AgendaNov 16

11:00 am EDT

Welcome

Virtual / In-Person

The War on Cancer, Revisited

Virtual / In-Person

Pfizer Presents: Bringing the Power of Collaboration to Health-care Delivery

Virtual / In-Person

The Frontlines of Research

Virtual / In-Person

GSK Presents: How Clues in our DNA are Uncovering New Opportunities to Advance Cancer Research

Virtual / In-Person

Screenings for All

Virtual / In-Person

Breakout Session - Bristol Myers Squibb Presents: The Future of Cancer Care: Transformative Innovation for All

Virtual / In-Person

Eliminating Prostate Cancer

Virtual / In-Person

A session produced by Astrazeneca

Virtual / In-Person

Why There’s No Cure for Brain Cancer, Yet

Virtual / In-Person

Breakout Session - GSK Presents: Exploring the Future of Immuno-Oncology (IO)

Virtual / In-Person

The Youngest Patients

Virtual / In-Person

New Innovations and the Future of Lung Cancer Care

Virtual / In-Person

Takeda Presents: The Future of Oncology: Precision Medicine and Comprehensive Diagnostic Testing

Virtual / In-Person

Finding Hope

Virtual / In-Person
3:55 pm EDT

Closing Remarks

Virtual / In-Person

Founding

Presenting

Event Details

Virtual Event

Tuesday, November 16, 2021

11:00 am EDT

Sponsorship

Underwriter Opportunities

jmj@theatlantic.com

Audience

Audience Engagement

events_audience@theatlantic.com

Speakers

Speaker Pitches

speakerpitches@theatlantic.com